Pharmafile Logo

JMC Partners LLP

JMC Partners is an established communications consultancy, with a particular expertise in healthcare. We have an excellent record of informing and influencing public policy on behalf of our clients. In a constantly evolving public policy environment, we work together with our clients to help them navigate the political process and convey their message to the people that count in Westminster and beyond. Our dedicated team provides a truly personalised service based on a genuine understanding of our clients’ goals and aspirations. We pride ourselves on the relationships we build and the results we achieve.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Visions4Health

Visions4Health are market access experts and your gateway to local adoption at pace. Leveraging our lived experience, understanding of national and local healthcare systems, and insights generated by our stakeholder…

View Profile

Company Details

Hudson House, 8 Tavistock Street, London, WC2E 7PP, United Kingdom
020 3178 7569

 Latest Content from PMHub 

Cuttsy+Cuttsy gain highly regarded PIF Partner status

As official PIF Partners, Cuttsy+Cuttsy will be supporting the Patient Information Forum raise awareness of the PIF TICK.

Science for science sake

Like great works of art, there was no ‘reason’ for certain scientific endeavours, but this ‘just for the sake of it’ philosophy is now delivering tangible benefits. (article written 3rd...

Embrace mental health first aiders for better work wellbeing

Mental health first aid can work as a vital steppingstone to instilling good mental health practices into wider company culture and ensure everyone knows what to be looking out for...

Celebrating World Blood Donor Day

Each 14th June World Blood Donor day is celebrated around the world to spread awareness around the importance of giving blood.

Spending on anti-depressants soars as the pandemic’s effect on NHS prescribing patterns is revealed

Wilmington Healthcare’s State of the Nation prescribing report shows that spending on sertraline, commonly used to treat depression and anxiety, increased by 305.5% between 2019/20 and 2020/21 while overall spend...

Accelerating patient recruitment in clinical trials post COVID-19

Patient recruitment is arguably one of the most important aspects of a clinical trial. Without enough participants, trials will inevitably fail, meaning potentially effective therapies will not be brought to...

Diversity in Clinical Trials: A more inclusive approach in patient recruitment

We have seen a growing focus on patient diversity in clinical trials in recent years, but the COVID-19 vaccine trials in particular have highlighted the importance of achieving diverse patient...

Part 4 of 4, of the Medscape video interview series

Dr. Hansa Bhargava MD interviews Dr. Maria Victoria Mateos on the most important abstracts to look out for in multiple myeloma and the potential implications of these data for managing patients...

How whole genome sequencing is revolutionising the rare disease patient experience

In this white paper, we discuss how whole genome sequencing (WGS) projects and the data sets they produce are paving the way for developments in research, diagnosis, and early interventions...

The Future of MedTech: Streamlined Clinical Data Collection & Management

Jón Ingi Bergsteinsson, Co-founder & CCO at SMART-TRIAL, explores the barriers to, and benefits of, digitalization of clinical operations and trials in the MedTech industry, plus much more!